Arkema stock backs a EUR 10 million battery research expansion

Published on 10/04/2026 at 21:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Arkema reported Q2 2026 EBITDA of EUR 391 million, up 7 percent year over year. The October 2 quote was EUR 53.85 after a 0.28 percent decline.

Architektonisches Rendering eines modernen verglasten Bürogebäudes mit Vorplatz und Bäumen — Architektur-Render eines modernen Glasbürogebäudes repräsentiert den Unternehmenssitz von Arkema S.A. FR0010313833 nahe Colombes, Illustration mit AI erstellt.

Arkema stock (ISIN FR0010313833) was last at EUR 53.85 on Euronext Paris on October 2, 2026 at 5:35 p.m. CEST, down 0.28 percent on the session. The specialty chemicals group is putting EUR 10 million into battery research, giving the market a concrete growth project as investors weigh uneven chemical demand.

Battery research gets EUR 10 million

According to Arkema on October 1, 2026, the expansion will triple the footprint of its Global Battery Center of Excellence in Oullins-Pierre-Benite, France. The project also includes modernized infrastructure and greater digitalization of research activities.

The investment links Arkema's advanced materials strategy to battery manufacturing requirements. Its researchers will work with customer production conditions to accelerate materials development for energy density, charging speed and safety. That is a longer-cycle growth signal rather than an immediate earnings contribution.

Q2 earnings set the benchmark

Arkema's second-quarter 2026 results provide the financial benchmark. In its earnings call, Yahoo Finance reported that EBITDA rose 7 percent year over year to EUR 391 million in Q2 2026, while revenue reached EUR 2.4 billion and adjusted net income was EUR 129 million.

Management confirmed slight EBITDA growth at constant exchange rates for fiscal year 2026, while Q2 sales increased 3.2 percent organically. The counter-factor is volume: Q2 volumes fell 1.8 percent, with weaker demand in Europe and North America, even as pricing and product mix supported profitability.

Consensus target remains above the quote

According to MarketScreener, the consensus rating is Outperform from 14 analysts, with an average target of EUR 62.93. The page lists a last close of EUR 57.50 and a 9.44 percent spread to the average target, while the October 2 quote stood at EUR 53.85.

The next operational checkpoint is leadership in specialty materials. Arkema said on September 28, 2026, that François Desne will become Senior Vice President for High Performance Polymers and Fluorogases on October 12, 2026.

Arkema stock remains below its yearly high

Arkema stock was last at EUR 53.85 on Euronext Paris on October 2, 2026 at 5:35 p.m. CEST. Its 52-week range was EUR 48.30 to EUR 67.05, with a market capitalization of EUR 4.1 billion and volume of 356,318 shares.